SummaryRMgm-4602
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene mutation |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 30941868 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | 8417HP |
Other information parent line | |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | Pace T, Ponzi M, Olivieri A |
Name Group/Department | Dipartimento di Malattie Infettive |
Name Institute | Istituto Superiore di Sanità |
City | Rome |
Country | Italy |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-4602 |
Principal name | SUB1/asex |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not different from wild type |
Gametocyte/Gamete | Normal gametocyte production. Significant reduction in male gamete formation (exflagellation). The proportion of non-released male gametes (inside PVM/red blood cells) after activation was significantly higher in the SUB1/asex line compared to wt parasites. In addition, the proportion of non-released male gametes still possessing an intact PVM was significantly higher in the SUB1/asex line than in the wt parasites. |
Fertilization and ookinete | Not tested |
Oocyst | Not tested |
Sporozoite | Not tested |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation Protein (function) Phenotype 'The SUB1/asex line was characterized by IFA and western blot analysis. In both cases, PbSUB1 was found to be expressed in transgenic schizonts in a similar manner to wt parasites, while it was not detected in SUB1/asex gametocytes'. |
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_1107100 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_0507500 | ||||||||||||||||||||||||||
Gene product | subtilisin-like protease 1 | ||||||||||||||||||||||||||
Gene product: Alternative name | SUB1 | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Short description of the mutation | 'promoter swap mutant': the promoter of sub1 replaced with the ama1 promoter (PBANKA_0915000). | ||||||||||||||||||||||||||
Inducable system used | No | ||||||||||||||||||||||||||
Short description of the conditional mutagenesis | Not available | ||||||||||||||||||||||||||
Additional remarks inducable system | |||||||||||||||||||||||||||
Type of plasmid/construct | (Linear) plasmid double cross-over | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||||||||||
Promoter of the selectable marker | pbdhfr | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | To produce the Sub1/asex construct, a gene targeting construct was made by modifying the plasmid pL1313 designed for targeted gene disruption by double cross-over homologous recombination [29]. A 956 bp 5′-targeting region and a 1006 bp 3′ targeting region were amplified from P. berghei genomic DNA using primer pairs sub1-swap-L and sub1-swap-R and cloned into the pL1313 plasmid digested with KpnI-HindIII and NcoI-SacII respectively. The 5’-targeting region includes a DNA sequence upstream of pbsub1 start codon (-1420 bp to -477), while the 3′ targeting region includes part of the coding sequence (-107 bp to +881 bp from pbsub1start codon). The coding region was sequenced with the primers SUB1_seq1 and SUB1_seq2 to confirm that no mutations were introduced during the amplification process. The AMA1 promoter, amplified by genomic DNA with the primer pairs sub1-swap-prAMA1, was then cloned into the resulting plasmid digested with EcoRV/BamHI | ||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |